Skip Navigation

Radiation Protection Dosimetry 2009 134(2):107-112; doi:10.1093/rpd/ncp088
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kramer, G. H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kramer, G. H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Canadian national internal dosimetry performance testing programme: results of the pilot programme

Gary H. Kramer*

National Internal Radiation Assessment Section, Radiation Protection Bureau, 775 Brookfield Road, PL6302D, Ottawa, ON, Canada K1A 1C1

* Corresponding author: gary_h_kramer{at}hc-sc.gc.ca

Received January 7, 2009, amended April 16, 2009, accepted April 25, 2009

This paper describes the design and construction of a new performance testing programme that was implemented in Canada in 2008. The Canadian Regulator (Canadian Nuclear Safety Commission) had determined that their licensees, in addition to participating in the existing in vivo and in vitro performance tests, needed to demonstrate their ability in interpreting bioassay results to obtain intakes and resulting doses. The new programme is administered by the Canadian National Calibration Reference Center for Bioassay and In Vivo Monitoring (NCRC). Currently, the NCRC carries out the performance testing for the in vitro and in vivo. At the time of writing, the first round has been completed and the results for 3H and natU exposures were very consistent, while the committed effective dose from 137Cs intake varied by a factor of two.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.